On 2/04/2020, RAPT Therapeutics filed the paperwork for a $99.3 million offering of its common stock. The South San Francisco based clinical stage company is focused on developing oral small... read more
On 2/04/2020, RAPT Therapeutics filed the paperwork for a $99.3 million offering of its common stock. The South San Francisco based clinical stage company is focused on developing oral small... read more
Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results
... read moreAccording to statistics, over 10 million people die from cancer every year. This is one of the leading causes of... read more
On 1/22/20 Seelos Therapeutics filed the paperwork for a $14 million offering of its common stock. The NY, NY based clinical-stage company is focused on developing products to address unmet needs... read more
On 1/15/2020 ADiTxt filed the paperwork for their $25 Million IPO. The offering will consist of common stock and warrants. The Loma Linda, CA based company is focused on developing treatments that... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,